The use of S-Ketamine, an FDA-approved medication for treatment-resistant depression, in rodents following chronic unpredictable stress produces increased brain-derived neurotrophic factor (BDNF) and SIRT1 [78]. The gene discussed is BDNF; the disease is major depressive disorder.